TY - JOUR
T1 - Analysis of TEL proteins in human leukemias
AU - Poirel, Hélène
AU - Lacronique, Virginie
AU - Mauchauffé, Martine
AU - Le Coniat, Maryvonne
AU - Raffoux, Emmanuel
AU - Daniel, Marie Thérèse
AU - Erickson, Paul
AU - Drabkin, Harry
AU - MacLeod, Roderick A.F.
AU - Drexler, Hans G.
AU - Ghysdael, Jacques
AU - Berger, Roland
AU - Bernard, Olivier A.
N1 - Funding Information:
We thank V Della Valle for help in cell culture, S Smith for the gift of the UOC B6 cell line, JM Cayuela for valuable reagents and E Macintyre for critical reading of the manuscript. This work was supported by funds from INSERM, CNRS, Institut Curie, Association pour la Recherche sur le Cancer, Ligue Nationale Contre le Cancer, Ligue Nationale Contre le Cancer (Comitéde Paris), and Biomed Program of the European Community (contract BMH1-CT94-1703).
PY - 1998/6/4
Y1 - 1998/6/4
N2 - Chromosomal translocations involving the human 12p13 band frequently affect the TEL gene, usually resulting in gene fusion between TEL and genes encoding proteins of various types. The most frequent 12p13 translocation is the t(12;21)(p13;q22), which recombines TEL with the AML1 gene on chromosome 21 and is frequently associated with deletion of the untranslocated TEL allele. Using antisera against different parts of TEL and against the AML1 proteins, we undertook Western blot and immunofluorescence analyses of leukemic samples with and without 12p13 abnormalities. In t(12;21) samples, TEL-AML1 was detected as several protein species in the nuclei, whereas the AML1-TEL protein, was inconsistently expressed. AML1 was found to be expressed but no normal TEL proteins were detected. A survey of the TEL proteins in a panel of human leukemic samples without t(12;21) revealed a variation in the ratio of TEL protein isoforms. We also analysed a leukemic cell line bearing a t(12;22)(p13;q11) that was found to affect the 5' untranslated (UT) region of TEL and to be associated with inactivation of the untranslocated TEL allele. No MN1-TEL fusion could be detected upon RT-PCR analysis, in contrast to the previously investigated t(12;22). Strikingly, extremely low levels of apparently normal TEL proteins, expressed from the translocated allele, were detected by Western blot analysis. These results suggest that the level of TEL expression can be important for leukemogenesis.
AB - Chromosomal translocations involving the human 12p13 band frequently affect the TEL gene, usually resulting in gene fusion between TEL and genes encoding proteins of various types. The most frequent 12p13 translocation is the t(12;21)(p13;q22), which recombines TEL with the AML1 gene on chromosome 21 and is frequently associated with deletion of the untranslocated TEL allele. Using antisera against different parts of TEL and against the AML1 proteins, we undertook Western blot and immunofluorescence analyses of leukemic samples with and without 12p13 abnormalities. In t(12;21) samples, TEL-AML1 was detected as several protein species in the nuclei, whereas the AML1-TEL protein, was inconsistently expressed. AML1 was found to be expressed but no normal TEL proteins were detected. A survey of the TEL proteins in a panel of human leukemic samples without t(12;21) revealed a variation in the ratio of TEL protein isoforms. We also analysed a leukemic cell line bearing a t(12;22)(p13;q11) that was found to affect the 5' untranslated (UT) region of TEL and to be associated with inactivation of the untranslocated TEL allele. No MN1-TEL fusion could be detected upon RT-PCR analysis, in contrast to the previously investigated t(12;22). Strikingly, extremely low levels of apparently normal TEL proteins, expressed from the translocated allele, were detected by Western blot analysis. These results suggest that the level of TEL expression can be important for leukemogenesis.
KW - AML1 proteins
KW - Acute leukemias
KW - Gene inactivation
KW - TEL/ETV6 proteins
KW - t(12;21) translocation
UR - http://www.scopus.com/inward/record.url?scp=7344240473&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1201817
DO - 10.1038/sj.onc.1201817
M3 - Article
C2 - 9671410
AN - SCOPUS:7344240473
SN - 0950-9232
VL - 16
SP - 2895
EP - 2903
JO - Oncogene
JF - Oncogene
IS - 22
ER -